Page last updated: 2024-09-03

olmesartan medoxomil and Embryopathies

olmesartan medoxomil has been researched along with Embryopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Celentano, C; di Vera, E; Gallo, DP; Iannicco, A; Liberati, M; Prefumo, F1

Other Studies

1 other study(ies) available for olmesartan medoxomil and Embryopathies

ArticleYear
Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker.
    Pediatric nephrology (Berlin, Germany), 2008, Volume: 23, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Diuretics; Female; Fetal Diseases; Furosemide; Gestational Age; Humans; Imidazoles; Infant, Newborn; Male; Maternal Exposure; Oligohydramnios; Olmesartan Medoxomil; Pregnancy; Prenatal Diagnosis; Recovery of Function; Renal Insufficiency; Tetrazoles; Treatment Outcome

2008